TWD 23.35
(-9.85%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 11.82 Million TWD | -1.27% |
2022 | 89.39 Million TWD | 8.25% |
2021 | 82.58 Million TWD | 27.22% |
2020 | 64.91 Million TWD | 28.29% |
2019 | 50.59 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 23.69 Million TWD | 2312.61% |
2024 Q2 | 32.03 Million TWD | -97.27% |
2023 Q1 | 17.76 Million TWD | 0.0% |
2023 FY | 88.25 Million TWD | -1.27% |
2023 Q2 | 21.47 Million TWD | 20.85% |
2022 FY | 89.39 Million TWD | 8.25% |
2021 FY | 82.58 Million TWD | 27.22% |
2020 FY | 64.91 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -3494.833% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 90.736% |
Level Biotechnology Inc. | 151.99 Million TWD | 92.219% |
Sagittarius Life Science Corp | 135.85 Million TWD | 91.294% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 84.409% |
TaiMed Biologics Inc. | 225.23 Million TWD | 94.749% |
GlycoNex Incorporation | 995 Thousand TWD | -1088.643% |
VBI | 32.55 Million TWD | 63.671% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 95.396% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 93.909% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 74.302% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 90.137% |
Visgeneer Inc. | 67.48 Million TWD | 82.474% |
Mycenax Biotech Inc. | -375.19 Million TWD | 103.152% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 97.681% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 81.492% |
Neith Corporation | 66.87 Million TWD | 82.314% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 99.181% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | 59.706% |
Enimmune corporation | 220.1 Million TWD | 94.627% |
TaiRx, Inc. | 217.13 Million TWD | 94.553% |
CHO Pharma, Inc. | 268.99 Million TWD | 95.603% |
EirGenix Inc. | 236.74 Million TWD | 95.004% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 88.666% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 96.693% |
Lin BioScience, Inc. | 1.09 Billion TWD | 98.922% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 95.556% |
Feng Chi Biotech Corp. | 49.47 Million TWD | 76.093% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -992.059% |
Lukas Biomedical Inc. | 177.45 Million TWD | 93.335% |
RBC Bioscience Corporation | 58.35 Million TWD | 79.733% |
BiOptic Inc. | 108.69 Million TWD | 89.119% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -13041.111% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 82.946% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -352.275% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 98.163% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 87.329% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 93.799% |
Sinew Pharma Inc. | 186.25 Million TWD | 93.65% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 84.023% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 94.634% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 71.488% |
AP Biosciences Inc | 32.25 Million TWD | 63.331% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 99.361% |
3D Global Biotech Inc. | 5.27 Million TWD | -124.251% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 96.273% |
Intech Biopharm Corporation | -163.99 Million TWD | 107.212% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 98.953% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 71.489% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 93.025% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 91.956% |
TCI GENE Inc. | 174.61 Million TWD | 93.227% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -65605.556% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 96.07% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 95.935% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 85.911% |
PharmaEngine, Inc. | 441.78 Million TWD | 97.323% |
Savior Lifetec Corporation | 223.36 Million TWD | 94.705% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 95.43% |
OBI Pharma, Inc. | 2.01 Billion TWD | 99.413% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 91.483% |
Acepodia, Inc. | 452.56 Million TWD | 97.387% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 97.814% |